Status:
COMPLETED
Population-based Study in Screening for Liver Fibrosis
Lead Sponsor:
Judit Pich Martínez
Conditions:
Liver Diseases
Eligibility:
All Genders
40+ years
Brief Summary
Study to assess the prevalence of significant liver fibrosis in general population using Transient Elastography
Detailed Description
This is a population-based study. Subjects will attend a primary care center where a physical examination, general blood test and transient elastography will be carried out. Only the group of patients...
Eligibility Criteria
Inclusion
- Age ≥ 40 years
- Able to give informed consent
Exclusion
- Previously known chronic liver disease (including cholestasis). Patients with already known liver steatosis but no diagnosis of liver fibrosis or cirrhosis can be included
- Subjects with mental incapacity, language barrier, insufficient social support or any other reason considered by the investigator precluding adequate understanding or cooperation in the study
- Subjects with a history of current malignancy including solid tumors and hematologic disorders
- Subjects with significant extrahepatic disease that may impair short-term prognosis (including congestive heart failure New York Heart Association Grade IV, COPD GOLD \>3)
- Subjects with kidney disease (serum creatinine \>3mg/dL or under renal replacement therapy)
Key Trial Info
Start Date :
March 19 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 7 2025
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT03789825
Start Date
March 19 2018
End Date
January 7 2025
Last Update
January 17 2025
Active Locations (45)
Enter a location and click search to find clinical trials sorted by distance.
1
Dubrava Hospital
Zagreb, Croatia, 10000
2
Poliklinika Croatia
Zagreb, Croatia, 1000
3
Odense University Hospital
Odense, Denmark
4
Centre de santé Municipal Etienne Gatineau-Sailliant de Genevilliers
Gennevilliers, France, 92230